Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 25 | 2026 | 857 | 3.620 |
Why?
|
| Heart Failure | 21 | 2026 | 2161 | 2.100 |
Why?
|
| Heart-Assist Devices | 16 | 2026 | 1028 | 1.950 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2024 | 167 | 0.830 |
Why?
|
| Heart Defects, Congenital | 7 | 2025 | 1838 | 0.830 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.750 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2024 | 154 | 0.700 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 80 | 0.690 |
Why?
|
| Child | 45 | 2026 | 25070 | 0.680 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 201 | 0.630 |
Why?
|
| Organ Transplantation | 1 | 2022 | 174 | 0.620 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 104 | 0.590 |
Why?
|
| Tracheostomy | 1 | 2020 | 214 | 0.560 |
Why?
|
| Retrospective Studies | 33 | 2025 | 16782 | 0.550 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 175 | 0.550 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 301 | 0.540 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 442 | 0.530 |
Why?
|
| Graft Rejection | 7 | 2026 | 554 | 0.530 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 248 | 0.510 |
Why?
|
| Clostridium Infections | 1 | 2019 | 242 | 0.490 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 47 | 0.480 |
Why?
|
| Cardiomyopathies | 5 | 2026 | 491 | 0.480 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1132 | 0.470 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 108 | 0.470 |
Why?
|
| Stroke Volume | 2 | 2023 | 490 | 0.450 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 254 | 0.390 |
Why?
|
| Humans | 55 | 2026 | 125950 | 0.390 |
Why?
|
| Postoperative Complications | 4 | 2022 | 2978 | 0.380 |
Why?
|
| Child, Preschool | 18 | 2025 | 14350 | 0.360 |
Why?
|
| Adolescent | 20 | 2025 | 19942 | 0.340 |
Why?
|
| Infant | 14 | 2025 | 12782 | 0.300 |
Why?
|
| Female | 27 | 2026 | 67908 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 136 | 0.280 |
Why?
|
| Male | 25 | 2025 | 62094 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2024 | 969 | 0.270 |
Why?
|
| Isoantibodies | 1 | 2026 | 62 | 0.240 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 169 | 0.230 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2026 | 64 | 0.230 |
Why?
|
| Glutathione Transferase | 1 | 2026 | 143 | 0.230 |
Why?
|
| Methylprednisolone | 1 | 2025 | 90 | 0.220 |
Why?
|
| HLA Antigens | 1 | 2026 | 217 | 0.220 |
Why?
|
| Treatment Outcome | 11 | 2025 | 12352 | 0.220 |
Why?
|
| Young Adult | 9 | 2026 | 9596 | 0.220 |
Why?
|
| Allografts | 1 | 2024 | 183 | 0.200 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 173 | 0.200 |
Why?
|
| Registries | 3 | 2025 | 1473 | 0.200 |
Why?
|
| Myocarditis | 1 | 2024 | 125 | 0.190 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 42 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2023 | 467 | 0.190 |
Why?
|
| Transplants | 1 | 2022 | 35 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 295 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2024 | 4892 | 0.190 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8374 | 0.190 |
Why?
|
| Warfarin | 1 | 2023 | 109 | 0.190 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 270 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.180 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 5089 | 0.180 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 32 | 0.170 |
Why?
|
| Hemolysis | 1 | 2021 | 102 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 641 | 0.170 |
Why?
|
| Prognosis | 6 | 2024 | 4691 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2021 | 268 | 0.170 |
Why?
|
| Patient Selection | 1 | 2024 | 698 | 0.170 |
Why?
|
| Heart Rate | 1 | 2023 | 563 | 0.170 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 43 | 0.170 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 714 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 166 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 208 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 259 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 522 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 644 | 0.160 |
Why?
|
| Down Syndrome | 1 | 2022 | 200 | 0.160 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 124 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 199 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 210 | 0.150 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 118 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 369 | 0.150 |
Why?
|
| Risk Factors | 6 | 2024 | 10355 | 0.150 |
Why?
|
| Heart Ventricles | 2 | 2013 | 748 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2023 | 484 | 0.140 |
Why?
|
| Capillaries | 1 | 2018 | 69 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 236 | 0.140 |
Why?
|
| Inflammation | 1 | 2025 | 1431 | 0.140 |
Why?
|
| Heart | 2 | 2022 | 645 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2022 | 1179 | 0.130 |
Why?
|
| Transplant Recipients | 3 | 2026 | 230 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 495 | 0.130 |
Why?
|
| Length of Stay | 2 | 2020 | 1314 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2021 | 342 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 333 | 0.130 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 138 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1107 | 0.130 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 269 | 0.130 |
Why?
|
| Graft Survival | 3 | 2024 | 453 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 387 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2016 | 62 | 0.120 |
Why?
|
| Recurrence | 1 | 2019 | 1408 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 998 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 601 | 0.120 |
Why?
|
| Age Factors | 1 | 2021 | 2762 | 0.110 |
Why?
|
| Diastole | 1 | 2015 | 168 | 0.110 |
Why?
|
| Adult | 10 | 2024 | 30262 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3573 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 164 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 76 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 283 | 0.110 |
Why?
|
| Cardiac Volume | 1 | 2013 | 16 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 183 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2566 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2015 | 465 | 0.100 |
Why?
|
| Contrast Media | 1 | 2016 | 447 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 40 | 0.100 |
Why?
|
| United States | 3 | 2024 | 11159 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1751 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1096 | 0.090 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 112 | 0.090 |
Why?
|
| Survival Rate | 3 | 2025 | 2053 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 27 | 0.090 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 612 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2024 | 236 | 0.090 |
Why?
|
| Disease Progression | 1 | 2016 | 2102 | 0.080 |
Why?
|
| Hospitalization | 3 | 2024 | 1807 | 0.080 |
Why?
|
| Myocardium | 2 | 2024 | 835 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 503 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2022 | 800 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2023 | 559 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 966 | 0.060 |
Why?
|
| Obesity | 2 | 2021 | 2326 | 0.060 |
Why?
|
| Heart-Lung Transplantation | 1 | 2024 | 22 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1119 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2173 | 0.050 |
Why?
|
| Gadolinium | 1 | 2024 | 108 | 0.050 |
Why?
|
| Time Factors | 2 | 2025 | 6025 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 353 | 0.050 |
Why?
|
| Cicatrix | 1 | 2024 | 121 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 46 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 45 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 189 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 25 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 97 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 81 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 35 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 437 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 32 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 46 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 48 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2021 | 1640 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 137 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 46 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 333 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 101 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 70 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 273 | 0.040 |
Why?
|
| Antibodies | 1 | 2022 | 352 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 225 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 203 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 274 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1039 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 360 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 722 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 79 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1219 | 0.040 |
Why?
|
| Genotype | 1 | 2026 | 2602 | 0.040 |
Why?
|
| Benchmarking | 1 | 2020 | 128 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3297 | 0.040 |
Why?
|
| Echocardiography | 2 | 2018 | 1095 | 0.040 |
Why?
|
| Miniaturization | 1 | 2019 | 26 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 389 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1294 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 410 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 474 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 295 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 743 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 500 | 0.040 |
Why?
|
| Sternotomy | 1 | 2018 | 36 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 665 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 203 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 461 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 596 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 777 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 29 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3417 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 38 | 0.030 |
Why?
|
| Aorta | 1 | 2018 | 503 | 0.030 |
Why?
|
| Biomarkers | 1 | 2024 | 3143 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 735 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 114 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 2011 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 238 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 950 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1349 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 17590 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1635 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 27337 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 33185 | 0.010 |
Why?
|